Scilex Holding Company: shareholders and insiders

SCLXNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$1.25

November 16, 2026Market cap $11M

What Ploutos Investor adds for Scilex

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 82% since Aug 14, 2026, when the 10-Q these figures come from was filed ($6.76 then, $1.25 on Nov 16, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Aug 24, 2026, from their own Form 4 filings.

3 Form 4s

Bought on the market

–

nobody

Sold on the market

$13M

1 person

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%
  • Dec 30, 2025Scilex Holding Co
    Kind
  • Dec 29, 2025Scilex Holding Co
    Kind
  • Dec 26, 2025Scilex Holding Co
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by SCLX's officers and directors from 2023 up to November 16, 2025, 3 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%1 On a 13DJul 7, 2026 Latest filing
  • SCLX Stock Acquisition JV LLC
    Share of class11.4%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • SCLX Stock Acquisition JV LLC11.4%From the filing of Jul 7, 2026

    Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On April 15, 2025, the Issuer effected a reverse stock split of the Common Stock at a ratio of 1-for-35 (the "Reverse Stock Split"). The share information in this Amendment No. 6 reflects the effect of the Reverse Stock Split. On July 3, 2026, the Reporting Person entered into a letter agreement (the "Letter Agreement") with the Issuer and Quantum Scan Holdings, Inc. ("Q Scan"), pursuant to which the Reporting Person transferred 500,000 shares of Common Stock held by the Reporting Person to Q Scan in exchange for shares of common stock of Q Scan. The price at which such shares are being transferred to Q Scan will be…

    From the filing of Jul 7, 2026
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Oramed Pharmaceuticals Inc.4.90%Feb 13, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter-5.1%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.75% of its shares outstanding were held short, -13.3% since the report before.

Shares held short
148.4K
1.75%
Since the report before171.2K on Sep 30, 2026
-13.3%
2.6
56.4K
More days to cover thanof 4,578 US-listed companies with enough volume
31%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 4.88M
  • Nov 15, 2023: Shares held short 5.08M
  • Nov 30, 2023: Shares held short 5.10M
  • Dec 15, 2023: Shares held short 4.99M
  • Dec 29, 2023: Shares held short 5.29M
  • Jan 12, 2024: Shares held short 5.96M
  • Jan 31, 2024: Shares held short 6.96M
  • Feb 15, 2024: Shares held short 7.20M
  • Feb 29, 2024: Shares held short 7.24M
  • Mar 15, 2024: Shares held short 6.79M
  • Mar 28, 2024: Shares held short 6.58M
  • Apr 15, 2024: Shares held short 7.34M
  • Apr 30, 2024: Shares held short 8.62M
  • May 15, 2024: Shares held short 8.08M
  • May 31, 2024: Shares held short 7.08M
  • Jun 14, 2024: Shares held short 7.92M
  • Jun 28, 2024: Shares held short 8.92M
  • Jul 15, 2024: Shares held short 8.28M
  • Jul 31, 2024: Shares held short 8.82M
  • Aug 15, 2024: Shares held short 8.23M
  • Aug 30, 2024: Shares held short 8.84M
  • Sep 13, 2024: Shares held short 9.32M
  • Sep 30, 2024: Shares held short 11.08M
  • Oct 15, 2024: Shares held short 12.16M
  • Oct 31, 2024: Shares held short 11.04M
  • Nov 15, 2024: Shares held short 5.40M
  • Nov 29, 2024: Shares held short 6.14M
  • Dec 13, 2024: Shares held short 5.28M
  • Dec 31, 2024: Shares held short 4.91M
  • Jan 15, 2025: Shares held short 4.84M
  • Jan 31, 2025: Shares held short 4.34M
  • Feb 14, 2025: Shares held short 6.10M
  • Feb 28, 2025: Shares held short 6.28M
  • Mar 14, 2025: Shares held short 6.05M
  • Mar 31, 2025: Shares held short 5.79M
  • Apr 15, 2025: Shares held short 240.8K
  • Apr 30, 2025: Shares held short 300.9K
  • May 15, 2025: Shares held short 297.0K
  • May 30, 2025: Shares held short 361.5K
  • Jun 13, 2025: Shares held short 446.1K
  • Jun 30, 2025: Shares held short 439.2K
  • Jul 15, 2025: Shares held short 430.1K
  • Jul 31, 2025: Shares held short 447.4K
  • Aug 15, 2025: Shares held short 481.4K
  • Aug 29, 2025: Shares held short 533.0K
  • Sep 15, 2025: Shares held short 563.5K
  • Sep 30, 2025: Shares held short 513.8K
  • Oct 15, 2025: Shares held short 279.7K
  • Oct 31, 2025: Shares held short 274.5K
  • Nov 14, 2025: Shares held short 271.1K
  • Nov 28, 2025: Shares held short 134.8K
  • Dec 15, 2025: Shares held short 134.0K
  • Dec 31, 2025: Shares held short 155.4K
  • Jan 15, 2026: Shares held short 171.3K
  • Jan 30, 2026: Shares held short 184.7K
  • Feb 13, 2026: Shares held short 232.7K
  • Feb 27, 2026: Shares held short 219.3K
  • Mar 13, 2026: Shares held short 190.8K
  • Mar 31, 2026: Shares held short 188.0K
  • Apr 15, 2026: Shares held short 159.0K
  • Apr 30, 2026: Shares held short 169.1K
  • May 15, 2026: Shares held short 158.0K
  • May 29, 2026: Shares held short 229.0K
  • Jun 15, 2026: Shares held short 203.1K
  • Jun 30, 2026: Shares held short 164.0K
  • Jul 15, 2026: Shares held short 209.2K
  • Jul 31, 2026: Shares held short 175.5K
  • Aug 14, 2026: Shares held short 152.6K
  • Aug 31, 2026: Shares held short 158.9K
  • Sep 15, 2026: Shares held short 176.7K
  • Sep 30, 2026: Shares held short 171.2K
  • Oct 15, 2026: Shares held short 148.4K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading40.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 40.5% of the shares in the reported trades were short sales, against 49.7% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
40.5%
The 14 beforeOct 8, 2026 – Oct 27, 2026
49.7%
Change
-9.2 pts
Short sales a dayon average, of 22.6K shares
9,142
More than atof 3,668 US-listed companies, same days
21%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 54.1%
  • Oct 9, 2026: Short sales 70.5%
  • Oct 12, 2026: Short sales 33.8%
  • Oct 13, 2026: Short sales 64.2%
  • Oct 14, 2026: Short sales 34.9%
  • Oct 15, 2026: Short sales 46.2%
  • Oct 16, 2026: Short sales 68.1%
  • Oct 19, 2026: Short sales 41.5%
  • Oct 20, 2026: Short sales 32.9%
  • Oct 21, 2026: Short sales 40.2%
  • Oct 22, 2026: Short sales 38.2%
  • Oct 23, 2026: Short sales 42.5%
  • Oct 26, 2026: Short sales 62.5%
  • Oct 27, 2026: Short sales 50%
  • Oct 28, 2026: Short sales 38.3%
  • Oct 29, 2026: Short sales 63.5%
  • Oct 30, 2026: Short sales 49.7%
  • Nov 2, 2026: Short sales 45.2%
  • Nov 3, 2026: Short sales 46.2%
  • Nov 4, 2026: Short sales 40.2%
  • Nov 5, 2026: Short sales 41.6%
  • Nov 6, 2026: Short sales 22.7%
  • Nov 9, 2026: Short sales 17.2%
  • Nov 10, 2026: Short sales 14%
  • Nov 11, 2026: Short sales 24.5%
  • Nov 12, 2026: Short sales 32.7%
  • Nov 13, 2026: Short sales 50.2%
  • Nov 16, 2026: Short sales 51.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

246M Insiders' shares2,899.96% Of the company
  • Scilex Holding CoTenPercentOwner
    Directly244M
  • SCLX Stock Acquisition JV LLC
    Directly958.3K
  • Henry JiExecutive Chairperson
    Directly320.2K
  • Jaisim ShahSee Remarks
    Directly139.3K
  • Jay ChunDirector
    Directly112.5K
  • Yue Alexander WuDirector
    Directly25.0K
  • Stephen Hoi MaChief Financial Officer
    Directly22.8K
  • Dorman FollowwillDirector
    Directly2,300
  • David LemusDirector
    Directly2,000

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%

3 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

73 Managers, Q2 2026$5.5M Value of their positions
  • Q3 2025: Managers 84
  • Q4 2025: Managers 82
  • Q1 2026: Managers 73
  • Q2 2026: Managers 73

Institutional investors by quarter

The fund managers holding SCLX, quarter by quarter, from Q4 2022 to Q2 2025, 11 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 73 managers held 702.8K shares, worth $5.5M. During the quarter 12 opened a position, 12 closed one, 10 added and 7 trimmed.

The largest holders, Q2 2026

  • Vanguard Capital Management
    In the quarter+14%
  • BlackRock
    In the quarter+6.4%
  • Vanguard Fiduciary Trust
    In the quarter+16%
  • Jacobs Levy Equity Management
    In the quarter
  • State Street
    In the quarter
  • UBS Group
    In the quarter+416%
  • Renaissance Technologies
    In the quarter-10%
  • Citadel Advisors (Griffin)
    In the quarter
  • Price T Rowe Associates
    In the quarter
  • Ashton Thomas Private Wealth
    In the quarter+2.7%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Scilex's filings show?

Who buys and sells is one part of Scilex's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SCLX's shareholders

Didn't find what you were looking for?

Ask us
Have SCLX's insiders bought or sold?

From Jun 26, 2026 to Aug 24, 2026 Scilex's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold SCLX?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $200.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.